ALA - delta-aminolevulinic acid
RxNorm 683
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 683 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ALA - delta-aminolevulinic acid.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PTPrescribable
Designated preferred name (PT):
5-aminolevulinic acid
(Atom ID: 10795146)
FNPrescribable
Full form of descriptor (FN):
5-aminolevulinic acid (substance)
(Atom ID: 10795147)
PTPrescribable
Designated preferred name (PT):
5-aminolevulinic acid-containing product
(Atom ID: 11823663)
SYPrescribable
Synonym (SY):
ALA - 5-aminolevulinic acid
(Atom ID: 20886)
SYPrescribable
Synonym (SY):
ALA - delta-aminolevulinic acid
(Atom ID: 10795319)
INPrescribable
Ingredient (IN):
Aminolevulinic acid
(Atom ID: 12253238)
SYPrescribable
Synonym (SY):
Aminolevulinic acid
(Atom ID: 20873)
SYPrescribable
Synonym (SY):
Delta-aminolevulinic acid
(Atom ID: 20879)
FNPrescribable
Full form of descriptor (FN):
Product containing 5-aminolevulinic acid (medicinal product)
(Atom ID: 11826200)
Patient Education
Aminolevulinic Acid Topical
Aminolevulinic acid is used in combination with photodynamic therapy (PDT; special blue light) to treat actinic keratoses (small crusty or scaly bumps or horns on or under the skin that result from exposure to sunlight and can develop into skin cancer) of the face or scalp. Aminolevulinic acid is in a class of medications called photosensitizing agents. When aminolevulinic acid is activated by light, it damages the cells of actinic keratosis lesions.
[Learn More]
* Please review the disclaimer below.